Sanofi ADR [SNY] stock is trading at $50.61, up 0.16%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The SNY shares have gain 3.20% over the last week, with a monthly amount glided 0.90%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Sanofi ADR [NASDAQ: SNY] stock has seen the most recent analyst activity on August 08, 2025, when JP Morgan upgraded its rating to a Overweight. Previously, Exane BNP Paribas started tracking the stock with Outperform rating on April 15, 2025, and set its price target to $65. On March 21, 2025, Goldman initiated with a Neutral rating and assigned a price target of $65 on the stock. Deutsche Bank upgraded its rating to a Hold. Argus reiterated its recommendation of a Buy and raised its price target to $60 on July 26, 2024. Morgan Stanley started tracking with a Equal-Weight rating for this stock on January 23, 2024, and assigned it a price target of $55.
Sanofi ADR [SNY] stock has fluctuated between $44.73 and $60.12 over the past year. Currently, Wall Street analysts expect the stock to reach $56 within the next 12 months. Sanofi ADR [NASDAQ: SNY] shares were valued at $50.61 at the most recent close of the market. An investor can expect a potential return of 10.65% based on the average SNY price forecast.
Analyzing the SNY fundamentals
Gross Profit Margin for this corporation currently stands at 0.72% with Operating Profit Margin at 0.37%, Pretax Profit Margin comes in at 0.31%, and Net Profit Margin reading is 0.21%. To continue investigating profitability, this company’s Return on Assets is posted at 0.07, Equity is 0.12 and Total Capital is 0.16. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.32.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 50.43 points at the first support level, and at 50.25 for the second support level. However, for the 1st resistance point, the stock is sitting at 50.89, and for the 2nd resistance point, it is at 51.17.
Ratios To Look Out For
For context, Sanofi ADR’s Current Ratio is 1.27. Further, the Quick Ratio stands at 0.94, while the Cash Ratio is 0.53. Considering the valuation of this stock, the price to sales ratio is 2.85, the price to book ratio is 1.50 and price to earnings (TTM) ratio is 12.64.
